Parameters of biological activity in colorectal cancer

Anticancer Research

Volumn 31, Issue 1, 2011, Pages 373-378

  Svobodova, Sarka ^a   Topolcan, Ondrej ^a   Holubec Jr , Lubos ^a   Levy, Miroslav ^a   Pecen, Ladislav ^b   Svacina, Stepan ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF COMPUTER SCIENCE   (Czech Republic)

Author keywords

Adhesion molecules; Angiogenetic factors; Biological activity; Colorectal cancer; Metalloproteinases; Tumor markers

Indexed keywords

ADIPONECTIN; C PEPTIDE; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; GELATINASE B; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 6; LEPTIN; THYMIDINE KINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE POLYPEPTIDE ANTIGEN; TISSUE POLYPEPTIDE SPECIFIC ANTIGEN; TUMOR ANTIGEN; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

AGED; ARTICLE; CANCER STAGING; CLINICAL PRACTICE; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; ONCOLOGICAL PARAMETERS; OVERALL SURVIVAL; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROTEIN BLOOD LEVEL;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; AGED; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREOPERATIVE CARE; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 79851471663     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Boyle P and Leon ME: Epidemiology of colorectal cancer. Br Med Bull 64: 1-25, 2002. (Pubitemid 35238576)
2. La Vecchia C, Llucchini F, Negri E, Boyle P, Maisonnevue P and Levi F: Trends in cancer mortality in Europe. Eur J Cancer 28: 132-235, 1992.
3. Pecen L, Topolcan O, Koukalova H, Novak J, Siroky P, Rousarova M, Holubec L Jr., Pikner R, Svobodova S: Epidemiology of colorectal carcinoma in the Czech Republic. J Tumor Marker Oncol 15(1): 55-56, 2000.
4. Ghesani M, Belgraier A and Hasni S: Carcinoembryonic antigen (CEA) scan in the diagnosis of recurrent colorectal carcinoma in a patient with increasing CEA levels and inconclusive computed tomographic findings. Clin Nucl Med 28(7): 608-609, 2003. (Pubitemid 38281937)
5. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Presinger AC, Leppert M, Nakamura Y, White R, Smits AM and Bos JL: Genetic alterations during colorectal-tumor development. N Engl J Med 319: 525-532, 1988.
6. Union Internationale Contre la Cancer: TMN Klassifikation maligner Tumoren. Springer-Verlag, Berlin, pp. 65-69, 1997.
7. Hundt S, Haug U and Brenner H: Blood markers for early detection of colorectal cancer: a systemic review. Cancer Epidemiol Biomarkers Prev 16(10): 1935-1953, 2007.
8. Holten Andersen MN, Christensen IJ, Nielsen HJ, Stephens RW, Jensen V, Nielsen OW and Soerensen S: Total levels of tissue inhibitor of metalloproteinases-1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancer. Clin Cancer Res 8: 156-164, 2002. (Pubitemid 34101472)
9. Docherty AJ, Lyons A, Smith BJ, Wright EM, Stephens PE, Harris TJ, Murphy G and Reynolds JJ: Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature 318(6041): 66-69, 1985. (Pubitemid 16230337)
10. Hayakawa T, Yamashita K, Tanzawa K, Uchijima E and Iwata K: Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for wide range of cells. A possible growth factor in serum. FEBS Lett 298: 29-32, 1992.
11. Guedez L, Stetler-Stevenson WG, Wolff L, Wang J, Fukushima P, Mansoor A and Stetler-Stevenson M: In vitro suppression of programmed cell death of B-cells by tissue inhibitor of metalloproteinases-1. Clin Investig 102: 2002-2010, 1998.
12. Li G, Fridman R and Kim HR: Tissue inhibitor of metalloproteinase-1 inhibits apoptosis of human breast epithelial cells. Cancer Res 59: 6267-6275, 1999. (Pubitemid 30035652)
13. Kaaks R, Toniolo P, Akhmedkhanov A, Lukanova A, Biessy C, Dechaud H and Rinaldi S: Serum C-peptide, IGF-1, IGF-binding proteins and colorectal cancer risk in women. J Natl Cancer Inst 92(19): 1592-1600, 2000.
14. Jenab M, Riboli E, Cleveland RJ, Norat T, Rinaldi S, Nieters A, Biessy C, Tjønneland A, Olsen A, Overvad K, Grønbaek H, Clavel-Chapelon F, Boutron-Ruault MC, Linseisen J, Boeing H, Pischon T, Trichopoulos D, Oikonomou E, Trichopoulou A, Panico S, Vineis P, Berrino F, Tumino R, Masala G, Peters PH, van Gils CH, Bueno-de-Mesquita HB, Ocké MC, Lund E, Mendez MA, Tormo MJ, Barricarte A, Martínez-García C, Dorronsoro M, Quirós JR, Hallmans G, Palmqvist R, Berglund G, Manjer J, Key T, Allen NE, Bingham S, Khaw KT, Cust A and Kaaks R: Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 121(2): 368-376, 2007. (Pubitemid 46917707)
15. Wei EK, Giovannucci E, Fuchs CS, Willett WC and Mantzoros CS: Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst 97(22): 1688-1694, 2005.
16. Ferroni P, Palmirotta R, Spila A, Martini F, Raparelli V, Fossile E, Mariotti S, Del Monte G, Buonomo O, Roselli M and Guadagni F: Prognostic significance of adiponectin levels in non-metastatic colorectal cancer. Anticancer Res 27(1B): 483-489, 2007.
17. Sugiyama M, Takahashi H, Hosono K, Endo H, Kato S, Yoneda K and Nozaki Y: Adiponectin inhibits colorectal cancer cell growth through the AMPK/mTOR pathway. Int J Oncol 34(2): 339-344, 2009.
18. Matsuda A, Matsutani Sasajima K, Furukawa K, Tajiri T, Tamura K and Kogo H: Preoperative plasma adiponectin level is a risk factor for postoperative infection following colorectal cancer surgery. J Surg Res 157(2): 227-234, 2009.
19. Duffy MJ, van Dalen A, Haglund C, Hansson L, Klapdor R, Lamerz R, Nilsson O, Sturgeon C and Topolcan O: Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines. Eur J Cancer 39(6): 718-727, 2003. (Pubitemid 36315986)
20. Duffy MJ, van Dalen A, Haglund C, Hansson L, Holinski-Feder E, Klapdor R, Lamerz R, Peltomaki P, Sturgeon C and Topolcan O: Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer 43(9): 1348-1360, 2007. (Pubitemid 46874070)
21. Vrzalova J, Prazakova M, Novotny Z, Topolcan O, Casova M and Holubec L Jr.: Test of ovarian cancer multiplex xMAP technology panel. Anticancer Res 29(2): 573-576, 2009.
22. Risk MC and Lin DW: New and novel markers for prostate cancer detection. Curr Urol Rep 10(3): 179-186, 2009.
23. Kim BK, Lee JW, Park PJ, Shin YS, Lee WY, Lee KA, Ye S, Hyun H, Kang KN, Yeo D, Kim Y, Ohn SY, Noh DY and Kim CW: The multiplex bead array approach to identifying serum biomarkers associated with breast cancer. Breast Cancer Res 11(2): R22, 2009.